glp-1 receptor agonist weight loss Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Balancing weight and muscle loss
Description
In a 10-week clinical trial, a daily dose of 20 mg oral semaglutide achieved a steady-state plasma concentration of 30 nM, and when daily dose of oral semaglutide was increased to 40 mg, the semaglutide plasma concentration reached about 60 nM (102), which was over a thousand times higher than the EC50 of semaglutide for GLP-1R activation (95)
Rare reports of clotting events have occurred in some people taking GLP-1 drugs, but health experts havent confirmed that the medications themselves caused the clots
504510, Feb
Some outcomes are already supported by large trials
What is the future of GLP-1 receptor agonists
J Diabetes Investig 2025;16:183-6.ArticlePubMed 105
